Agenda
Programs
Speaker Proposal
Attendee List
Testimonials
Archives
Sponsor/Exhibit
Attendee Demographics + Event Features
Sponsorship Opportunities
Current Sponsors
Sponsorship Prospectus
Current Exhibitors/Floorplan
Exhibit Services/Schedule
Lead Generation Opportunities
Downloads
Brochures
Travel
Posters
Poster Information
Poster Titles
Press
Register
Individual Pricing
Group Pricing
Speaker Proposal
* Please Select a Track
- Select -
Display of Biologics (PGD 240907)
Engineering Antibodies & Beyond (RAB 240912)
Machine Learning Approaches for Protein Engineering – Part 1 (AIBP 240916)
Machine Learning Approaches for Protein Engineering – Part 2 (AIBP2 240918)
Antibody-Based Cancer Therapies (ABC 240919)
Emerging Targets and Therapeutic Approaches (MOC 240904)
Antibodies Against Membrane Protein Targets (PMB 240917)
Safety and Efficacy of Multispecific Antibodies, ADCs, and Combination Therapies (BSC 240915)
Advancing Multispecifics and Combination Therapy to the Clinic (NAB2 240903)
Engineering the Next Generation of Bispecific Antibodies (NAB 240902)
Modulating the Tumour Microenvironment (TME 240901)
Innovative CAR T Therapy (CAR 240913)
Next-Generation Immunotherapies (IMX 240911)
Optimisation and Developability (RBE 240906)
Analytical Characterisation of Biotherapeutics (PPC 240909)
Protein Stability & Formulation (PAG 240908)
Using Data Science to Maximise Protein Production (SNB 240914)
Optimising Expression Platforms (PXE 240905)
Protein Process Development (PPF 240910)
Engineering Conjugates (ADC 240920)
Driving Clinical Success in Antibody-Drug Conjugates (ADC2 240921)
* Proposal Title:
* 2-3 Sentence Summary (approx. 70 words):
* Why your proposal should be considered:
* What the audience will gain from your presentation:
* Short Biography: (Bio may be used in print material if proposal is accepted)
* Select :
Mr.
Ms.
Mrs.
Dr.
Prof.
* First Name:
* Last Name:
Degree / Credential: (eg. Ph.D. or FACR etc.)
* Job Title:
* Department:
* Company/Organization:
* Mailing Address:
* City:
* State or Province (Canada):
* Zip / Postal Code:
* Country:
* Phone:
Ext:
*I would like to receive future notices and communications from CHI relevant to my interests through the following channels:
Email
None
*We may occasionally send you, via email, industry relevant product & service information on behalf of our marketing partners.
Yes, I want to receive this information.
No, I do not want to receive this information.
Fax:
*Professional Email:
Alternate Email:
Your Organization Website:
ORCID iD
LinkedIn Profile
Twitter Handle
Submit
#PEGSEurope
VIEW ALL SPONSORS
VIEW MEDIA PARTNERS
Conference Programs
Display of Biologics
Engineering Antibodies
Machine Learning - Part 2
Antibody-Based Therapies
Emerging Targets & Approaches
Membrane Protein Targets
Safety & Efficacy
Advancing Bispecifics
Engineering Bispecifics
Modulating the TME
Innovative CAR T Therapy
Next-Gen Immunotherapies
Optimisation & Developability
Analytical Characterisation
Protein Stability & Formulation
Data Science & Engineering
Optimising Expression
Process Development
Intro to Machine Learning
Machine Learning - Part 1
Machine Learning - Part 2
Antibody-based Therapies
Engineering Conjugates
Next-Gen Immunotherapies